Find your path to Karen
488 people in our graph can introduce you to Karen.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Vincent Brichard to introduce you to Karen
You →Vincent · together at Ludwig Institute for Cancer Research (1996) →Karen
Ask Jamie Chen to introduce you to Karen
You →Jamie · together at Ludwig Institute for Cancer Research →Karen
Ask Sam Okafor to introduce you to Karen
You →Sam · together at American Cancer Society →Karen
Sign up to find every way you can get introduced to Karen
- Your email: the people you already email who know Karen
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Karen
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
CEO of the Parker Institute for Cancer Immunotherapy and former CEO of the American Cancer Society. Serves on the boards of AstraZeneca and several biotech companies.
Experience
- Parker Institute for Cancer ImmunotherapyChief Executive Officer and Executive Directorcurrent2025 — present
- AstraZenecaBoard Membercurrent2025 — present
- Exai BioBoard Membercurrent2024 — present
- Paradigm HealthBoard Membercurrent2025 — present
- 3T BiosciencesBoard Membercurrent2025 — present
- ArteraAIBoard Advisorcurrent2023 — present
- TranscarentStrategic Advisor, Cancer Carecurrent2025 — present
- CellCentricAdvisory Board Membercurrent2025 — present
- GenentechAdvisory Board Membercurrent2019 — present
- Thomas Jefferson UniversityProfessor Emeritacurrent2020 — present
- Thomas Jefferson UniversityEndowed Professor of Cancer Biology, Radiation Oncology, Urology, and Medical Oncologycurrent2007 — present
- Thomas Jefferson UniversityChair and Hilary Koprowski Professor, Department of Cancer Biology2015 — 2021
- Thomas Jefferson UniversityDeputy Director, NCI-designated Sidney Kimmel Cancer Center2012 — 2015Philadelphia, PA
- Thomas Jefferson UniversityVice Provost2014 — 2015
- Research!America: Discovery. Innovation. Health.Board Member2023 — 2025
- American Cancer SocietyExecutive Strategic Advisor & Immediate Past CEO2024 — 2025
- American Cancer SocietyCEO, American Cancer Society and American Cancer Society Action Network2021 — 2024
- National Cancer Institute (NCI)Board Member, Board of Scientific Advisors2018 — 2024
- Association of American Cancer InstitutesPresident and Board Chair2020 — 2021
- Association of American Cancer InstitutesPresident Elect2018 — 2020
- American Association for Cancer ResearchMember Board of Directors2019 — 2021
- Sidney Kimmel Cancer Center – Jefferson HealthEVP Oncology Services & Enterprise Director, NCI-designated Sidney Kimmel Cancer Center at Jefferson2015 — 2021Greater Philadelphia Area
- University of CincinnatiAssociate Professor (with tenure) of Cancer Biology2005 — 2007
- University of CincinnatiAssistant Professor of Cancer Biology2000 — 2005
- Ludwig Institute for Cancer ResearchPostdoctoral Fellow1996 — 1999La Jolla, California
Skills & more
+1 more
LeadershipFrom Karen's professional profile.
Colleagues at Oncology Ventures
Frequently asked questions
- Who is Karen Knudsen?
- CEO of the Parker Institute for Cancer Immunotherapy and former CEO of the American Cancer Society. Serves on the boards of AstraZeneca and several biotech companies.
- Where does Karen Knudsen work?
- Karen Knudsen is Advisor at Oncology Ventures.
- Where did Karen Knudsen go to school?
- Karen Knudsen studied at UC San Diego (Doctor of Philosophy (Ph.D.), Molecular Biology); Fox School of Business at Temple University (Master of Business Administration - MBA); The George Washington University (BS Biology).
Same school
Also attended UC San Diego628
+ 622 more
Also attended Fox School of Business at Temple University45
+ 39 more
Also attended The George Washington University403
+ 397 more
Shared employers
Also worked at AstraZeneca167
+ 161 more
Also worked at 3T Biosciences4
Also worked at Sidney Kimmel Cancer Center – Jefferson Health1
Also worked at University of Cincinnati25
+ 19 more




























































